Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 9Rectal Neoplasms 4Stomach Neoplasms 3Liver Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Neoplasm Metastasis 2Thrombosis 1Pancreatic Intraductal Neoplasms 1Pancreatic Adenocarcinoma 1Ovarian Neoplasms 1Melanoma 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1Bites and Stings 1Bile Duct Neoplasms 1

Interventions

tocotrienol, delta 2Surgical Procedures, Operative 2Paclitaxel 2Erlotinib Hydrochloride 2dehydroftorafur 1dachengqi decoction 1X-Rays 1Tomography, Optical Coherence 1Therapeutic Irrigation 1Surveys and Questionnaires 1Sulindac 1Specimen Handling 1Secretin 1Saline Solution 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Phantoms, Imaging 1Pancreatectomy 1Octreotide 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Immunohistochemistry 1Hydrocortisone 1Gemcitabine 1Fluorouracil 1Ferrosoferric Oxide 1Ethanol 1Endosonography 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Intraductal Neoplasms × Radiotherapy, Conformal × Gastrointestinal × Clear all
NCT01013649 2026-02-23

Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

National Cancer Institute (NCI)

Phase 3 Completed
546 enrolled 29 charts
Gastrointestinal

Pancreatic Intraductal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡